-
1
-
-
0029024453
-
Neuroblastoma: A clinical challenge and biologic puzzle
-
Matthay KK: Neuroblastoma: a clinical challenge and biologic puzzle. CA Cancer J Clin 45: 179-192, 1995.
-
(1995)
CA Cancer J Clin
, vol.45
, pp. 179-192
-
-
Matthay, K.K.1
-
2
-
-
33646472266
-
Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors
-
Khan T, Stauffer JK, Williams R, Hixon JA, Salcedo R, Lincoln E, Back TC, Powell D, Lockett S, Arnold AC, Sayers TJ and Wigginton JM: Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors. J Immunol 176: 6302-6312, 2006.
-
(2006)
J Immunol
, vol.176
, pp. 6302-6312
-
-
Khan, T.1
Stauffer, J.K.2
Williams, R.3
Hixon, J.A.4
Salcedo, R.5
Lincoln, E.6
Back, T.C.7
Powell, D.8
Lockett, S.9
Arnold, A.C.10
Sayers, T.J.11
Wigginton, J.M.12
-
3
-
-
33745918631
-
Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells
-
Beevers CS, Li F, Liu L and Huang S: Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells. Int J Cancer 119: 757-764, 2006.
-
(2006)
Int J Cancer
, vol.119
, pp. 757-764
-
-
Beevers, C.S.1
Li, F.2
Liu, L.3
Huang, S.4
-
4
-
-
0035174504
-
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
-
Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC and Hsieh CY: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21: 2895-2900, 2001.
-
(2001)
Anticancer Res
, vol.21
, pp. 2895-2900
-
-
Cheng, A.L.1
Hsu, C.H.2
Lin, J.K.3
Hsu, M.M.4
Ho, Y.F.5
Shen, T.S.6
Ko, J.Y.7
Lin, J.T.8
Lin, B.R.9
Ming-Shiang, W.10
Yu, H.S.11
Jee, S.H.12
Chen, G.S.13
Chen, T.M.14
Chen, C.A.15
Lai, M.K.16
Pu, Y.S.17
Pan, M.H.18
Wang, Y.J.19
Tsai, C.C.20
Hsieh, C.Y.21
more..
-
5
-
-
30044446136
-
Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation
-
Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S and Aggarwal BB: Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 69: 195-206, 2006.
-
(2006)
Mol Pharmacol
, vol.69
, pp. 195-206
-
-
Aggarwal, S.1
Ichikawa, H.2
Takada, Y.3
Sandur, S.K.4
Shishodia, S.5
Aggarwal, B.B.6
-
6
-
-
4043111378
-
Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling
-
Aggarwal S, Takada Y, Singh S, Myers JN and Aggarwal BB: Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int J Cancer 111: 679-692, 2004.
-
(2004)
Int J Cancer
, vol.111
, pp. 679-692
-
-
Aggarwal, S.1
Takada, Y.2
Singh, S.3
Myers, J.N.4
Aggarwal, B.B.5
-
7
-
-
0033596121
-
Activators and target genes of Rel/NF-kappaB transcription factors
-
Pahl HL: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 49: 6853-6866, 1999.
-
(1999)
Oncogene
, vol.49
, pp. 6853-6866
-
-
Pahl, H.L.1
-
8
-
-
0014832212
-
Definition of a continuous human cell line derived from neuroblastoma
-
Tumilowicz JJ, Nichols WW, Cholon JJ and Greene AE: Definition of a continuous human cell line derived from neuroblastoma. Cancer Res 30: 2110-2118, 1970.
-
(1970)
Cancer Res
, vol.30
, pp. 2110-2118
-
-
Tumilowicz, J.J.1
Nichols, W.W.2
Cholon, J.J.3
Greene, A.E.4
-
9
-
-
0020044112
-
Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma, and teratoma cells with a monoclonal antibody
-
Seeger RC, Danon YL, Rayner SA and Hoover F: Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma, and teratoma cells with a monoclonal antibody. J Immunol 128: 983-989, 1982.
-
(1982)
J Immunol
, vol.128
, pp. 983-989
-
-
Seeger, R.C.1
Danon, Y.L.2
Rayner, S.A.3
Hoover, F.4
-
10
-
-
0015817744
-
Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture
-
Biedler JL, Helson L and Spengler BA: Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33: 2643-2652, 1973.
-
(1973)
Cancer Res
, vol.33
, pp. 2643-2652
-
-
Biedler, J.L.1
Helson, L.2
Spengler, B.A.3
-
11
-
-
33646093952
-
Anti-proliferative effect of peroxisome proliferator-activated receptor gamma agonists on human malignant melanoma cells in vitro
-
Freudlsperger C, Moll I, Schumacher U and Thies A: Anti-proliferative effect of peroxisome proliferator-activated receptor gamma agonists on human malignant melanoma cells in vitro. Anticancer Drugs 17: 325-332, 2006.
-
(2006)
Anticancer Drugs
, vol.17
, pp. 325-332
-
-
Freudlsperger, C.1
Moll, I.2
Schumacher, U.3
Thies, A.4
-
12
-
-
0017184389
-
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
-
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 7: 248-254, 1976.
-
(1976)
Anal Biochem
, vol.7
, pp. 248-254
-
-
Bradford, M.M.1
-
14
-
-
0037305821
-
Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis
-
Bharti AC, Donato N, Singh S and Aggarwal BB: Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101: 1053-1062, 2003.
-
(2003)
Blood
, vol.101
, pp. 1053-1062
-
-
Bharti, A.C.1
Donato, N.2
Singh, S.3
Aggarwal, B.B.4
-
15
-
-
23344450568
-
Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines
-
Ramachandran C, Rodriguez S, Ramachandran R, Raveendran Nair PK, Fonseca H, Khatib Z, Escalon E and Melnick SJ: Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res 35: 3293-3302, 2005.
-
(2005)
Anticancer Res
, vol.35
, pp. 3293-3302
-
-
Ramachandran, C.1
Rodriguez, S.2
Ramachandran, R.3
Raveendran Nair, P.K.4
Fonseca, H.5
Khatib, Z.6
Escalon, E.7
Melnick, S.J.8
-
16
-
-
4644295053
-
Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells
-
Karacay B, Sanlioglu S, Griffith TS, Sandler A and Bonthius DJ: Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells. Cancer Gene Ther 11: 681-690, 2004.
-
(2004)
Cancer Gene Ther
, vol.11
, pp. 681-690
-
-
Karacay, B.1
Sanlioglu, S.2
Griffith, T.S.3
Sandler, A.4
Bonthius, D.J.5
-
17
-
-
0036826891
-
Constitutively active NFkappa B is required for the survival of S-type neuroblastoma
-
Bian X, Opipari AW Jr, Ratanaproeksa AB, Boitano AE, Lucas PC and Castle VP: Constitutively active NFkappa B is required for the survival of S-type neuroblastoma. J Biol Chem 277: 42144-42150, 2002.
-
(2002)
J Biol Chem
, vol.277
, pp. 42144-42150
-
-
Bian, X.1
Opipari Jr, A.W.2
Ratanaproeksa, A.B.3
Boitano, A.E.4
Lucas, P.C.5
Castle, V.P.6
-
18
-
-
22144482343
-
Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells
-
Lee J, Im YH, Jung HH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, Park YS, Kang WK and Park K: Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells. Biochem Biophys Res Commun 334: 313-318, 2005.
-
(2005)
Biochem Biophys Res Commun
, vol.334
, pp. 313-318
-
-
Lee, J.1
Im, Y.H.2
Jung, H.H.3
Kim, J.H.4
Park, J.O.5
Kim, K.6
Kim, W.S.7
Ahn, J.S.8
Jung, C.W.9
Park, Y.S.10
Kang, W.K.11
Park, K.12
|